Loading...
Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults
VRC-HIVMAB060-00-AB (VRC01) is a broadly neutralizing HIV-1 monoclonal antibody (mAb) isolated from the B cells of an HIV-infected patient. It is directed against the HIV-1 CD4 binding site and is capable of potently neutralizing the majority of diverse HIV-1 strains. This Phase I dose-escalation st...
Na minha lista:
| Udgivet i: | Clin Exp Immunol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley & Sons, Ltd
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4636891/ https://ncbi.nlm.nih.gov/pubmed/26332605 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.12692 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|